Package 55150-393-01

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 55150-393-01
Digits Only 5515039301
Product NDC 55150-393
Product ID 55150-393_e89b9510-86df-4095-b6d3-4eb05b613c4f
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2023-01-03
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

AZACITIDINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e89b9510-86df-4095-b6d3-4eb05b613c4f", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0355150393015"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["ecd108bd-bb5f-4b2e-ad91-210fca452e9b"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01)  / 4 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-393-01", "marketing_start_date": "20230103"}], "brand_name": "AZACITIDINE", "product_id": "55150-393_e89b9510-86df-4095-b6d3-4eb05b613c4f", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "55150-393", "generic_name": "AZACITIDINE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZACITIDINE", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/4mL"}], "application_number": "ANDA215066", "marketing_category": "ANDA", "marketing_start_date": "20230103", "listing_expiration_date": "20261231"}